Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05823740 · ClinicalTrials.gov registry record · NA

Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers

A NA study of Cancer and Malignant Neoplasm, sponsored by UNC Lineberger Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT05823740 is a NA study of Cancer and Malignant Neoplasm that is active but no longer recruiting, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 28 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05823740, a NA study of Cancer and Malignant Neoplasm, is active but no longer recruiting, sponsored by UNC Lineberger Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to evaluate the feasibility and acceptability of obtaining repeated measurements of lean muscle mass, physical function, and biological aging in children receiving active cancer therapy. The secondary objective is to evaluate the feasibility of using the D3-creatine dilution method (D3Cr) to measure skeletal muscle mass in children with cancer. Assessments will be collected at diagnosis, once during active treatment, and end of treatment in coordination with routine imaging to monitor changes in study outcomes during active cancer treatment. Key sociodemographic, treatment and health-related factors will be abstracted from the medical record.

Interventions

  • OTHER Bioelectrical impedance Analysis (BIA)
  • OTHER D3-Creatine Dilution (D3Cr)
  • OTHER 6-Minute Walk Test (6MWT)
  • OTHER Timed Up and Go (TUG)
  • OTHER 30-second Sit-to-Stand (STS)

Study Locations (1)

North Carolina

  • UNC Lineberger Comprehensive Cancer Center - Chapel Hill

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2023-05-01
Est. Completion 2026-03-31
Phase NA

What the Registry Record Tells You About NCT05823740

The ClinicalTrials.gov registry entry for NCT05823740 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 5 interventions - of which Bioelectrical impedance Analysis (BIA) is the first listed.

NCT05823740 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05823740 about?

NCT05823740 is a clinical study titled "Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers". The primary objective of this study is to evaluate the feasibility and acceptability of obtaining repeated measurements of lean muscle mass, physical function, and biological aging in children receiving active cancer therapy. The secondary objective is to evaluate the feasibility of using the D3-cre...

What is the current status of trial NCT05823740?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2023-05-01. Estimated completion is 2026-03-31.

What conditions does trial NCT05823740 study?

This clinical trial studies the following conditions: Cancer, Malignant Neoplasm.

What interventions are being tested in trial NCT05823740?

The interventions under investigation include: Bioelectrical impedance Analysis (BIA) (OTHER), D3-Creatine Dilution (D3Cr) (OTHER), 6-Minute Walk Test (6MWT) (OTHER), Timed Up and Go (TUG) (OTHER), 30-second Sit-to-Stand (STS) (OTHER).

Who is sponsoring clinical trial NCT05823740?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05823740 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.